No abstract available
MeSH terms
-
3',5'-Cyclic-GMP Phosphodiesterases
-
Clinical Trials as Topic
-
Cyclic Nucleotide Phosphodiesterases, Type 5
-
Diabetes Complications
-
Diabetic Angiopathies / complications
-
Dose-Response Relationship, Drug
-
Drug Interactions
-
Enzyme Inhibitors / pharmacokinetics
-
Enzyme Inhibitors / therapeutic use
-
Erectile Dysfunction / drug therapy*
-
Erectile Dysfunction / etiology
-
Fees, Pharmaceutical
-
Humans
-
Imidazoles / pharmacokinetics
-
Imidazoles / therapeutic use*
-
Male
-
Phosphoric Diester Hydrolases / drug effects
-
Piperazines / pharmacokinetics
-
Piperazines / therapeutic use*
-
Prostatectomy / adverse effects
-
Sulfones
-
Triazines
-
Vardenafil Dihydrochloride
Substances
-
Enzyme Inhibitors
-
Imidazoles
-
Piperazines
-
Sulfones
-
Triazines
-
Vardenafil Dihydrochloride
-
Phosphoric Diester Hydrolases
-
3',5'-Cyclic-GMP Phosphodiesterases
-
Cyclic Nucleotide Phosphodiesterases, Type 5
-
PDE5A protein, human